Cybin Inc.
AMEX: CYBN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eric So
- Employees
- 50
- Headquarters
- Toronto, Canada
- IPO year
- 2019
- Market cap
- $413.0M
- Website
- https://www.cybin.com
Loading CYBN…
Loading profile data…Frequently asked questions about CYBN
What does Cybin Inc. (CYBN) do?
Cybin Inc. is a biopharmaceutical firm dedicated to pioneering treatments that leverage psychedelic compounds. Its research and development portfolio encompasses several key candidates: CYB003, a modified psilocybin compound targeting major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine designed to alleviate anxiet...
Where does CYBN trade?
Cybin Inc. (CYBN) trades on the New York Stock Exchange Arca.
What sector is CYBN in?
Cybin Inc. (CYBN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cybin Inc.?
Eric So is the chief executive officer of Cybin Inc. (CYBN).
Where is Cybin Inc. headquartered?
Cybin Inc. is headquartered in Canada.
Does CYBN pay a dividend?
Cybin Inc. (CYBN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CYBN go public?
Cybin Inc. (CYBN) completed its initial public offering in 2019.